SCHEMBL8093094

SCHEMBL8093094

N[C@H](COCCO)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.55
NOS1 P29475 2/20 0.55
NOS2 P35228 2/20 0.55
PTGS1 P23219 1/20 0.41
SLC7A11 Q9UPY5 1/20 0.41
SLC1A1 P43005 4/20 0.40
SLC1A5 Q15758 1/20 0.40
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
SLC7A5 Q01650 2/20 0.38
GSR P00390 2/20 0.38
GRIK1 P39086 2/20 0.38
GRIK2 Q13002 2/20 0.38
GRM1 Q13255 2/20 0.38
GRM2 Q14416 2/20 0.38
SLC1A3 P43003 2/20 0.38
SLC1A2 P43004 2/20 0.38
GRM8 O00222 1/20 0.38
GRM6 O15303 1/20 0.38
GRIN2D O15399 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL617875 1.00 NOS3 (0.55) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL6535740 1.00 NOS3 (0.55) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL890468 0.96 NOS3 (0.51) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL890472 0.96 NOS3 (0.51) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL22091990 0.87 NOS3 (0.51) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL22091993 0.87 NOS3 (0.51) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL31688563 0.84 NOS3 (0.53) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL17434420 0.83 NOS3 (0.53) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL9423322 0.83 NOS3 (0.53) NOS3NOS1NOS2PTGS1SLC7A11
SCHEMBL8892097 0.83 NOS3 (0.53) NOS3NOS1NOS2PTGS1SLC7A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101272780-A DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection NOVARTIS AG (CH) 2008-09-24 CN claimed
CN-1205220-C Novel cyclosporins CHEM AG C (CH) 2005-06-08 CN claimed
CN-1305493-A Novel cyclosporins CHEM AG C (CH) 2001-07-25 CN claimed
EP-0580690-B2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS NOVARTIS AG (CH) 2000-09-13 EP claimed
US-11260027-B2 Donor organ pre-treatment formulation MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2022-03-01 US disclosed
CN-110996985-A Composition for preventing and treating acute kidney injury AKI医疗有限公司 2020-04-10 CN disclosed
CN-101272780-A DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection NOVARTIS AG (CH) 2008-09-24 CN disclosed
CN-1205220-C Novel cyclosporins CHEM AG C (CH) 2005-06-08 CN disclosed
CN-1305493-A Novel cyclosporins CHEM AG C (CH) 2001-07-25 CN disclosed